“秉持严谨、深入、持续、开放与创新的态度,尊重他人成果,携手交流共进,推动科研发展。”
Research Frontline
科研前线
01
—
问题论文
标题:MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1
期刊:American Journal of Cancer Research
单位:郑州大学第一附属医院
发表时间:2017年8月1日
Pubmed: 28861329
研究摘要:
Current evidence indicates that microRNAs are widely down-regulated in various tumors including colorectal carcinoma, liver cancer and lung cancer, and function as tumor suppressors through inhibiting cancer cell growth, invasion and migration. Here, we demonstrated that miR-210-3p level was significantly reduced in the bladder cancer compared to paratumor tissues, and attempt to reveal the regulatory role of miR-210-3p in bladder cancer progression. Exogenous overexpression of miR-210-3p inhibited the proliferation, migration and invasion of bladder cancer cells in vitro. In addition, the nude mouse xenograft model showed that miR-210-3p over-expressing inhibited bladder cancer growth and liver metastasis whereas silencing miR-210-3p caused an opposite outcome, which is mainly regulated by targeting fibroblast growth factor receptor-like 1 (FGFRL1). We also demonstrated that the expression of FGFRL1 in bladder cancer specimens were negatively correlated with miR-210-3p level, and FGFRL1 overexpression rescued the cell proliferation and invasion inhibited by ectopic expression of miR-210-3p. Moreover, knockdown of FGFRL1 was able to mimic the cell growth and metastasis effects induced by miR-210-3p over-expressing in bladder cancer cells. Together, these results indicate that miR-210-3p plays an important role in the regulation of bladder cancer growth and metastasis in vitro and in vivo through targeting FGFRL1.
02
—
具体说明
参考信息
https://pubmed.ncbi.nlm.nih.gov/28861329/
https://pubpeer.com/publications/7C1F6E52442DD0565B0916316243DA#0
本平台对于科研问题的探讨,始终保持严谨、深入、持续、开放和创新的态度。所有推文信源,均来源于pubpeer、For Better Science等网站公开质疑。我们从来没有、也永远不会主动查重论文并去pubpeer上质疑。我们尊重他人的研究成果和贡献,通过交流和合作,共同推动科研领域的进步和发展。